Vaccine Developers Promise Diversity in Clinical Trials

July 31, 2020

Vaccine Developers Promise Diversity in Clinical Trials

Coronavirus vaccine developers have pledged their commitment to diversity in clinical trials. "Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," said Menelas Pangalos, AstraZeneca Plc's executive vice president of biopharmaceutical research & development. With an extensive global network and a direct-to-patient service offering, Yourway can bring trial supplies around the world in hours, not days.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?